Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Fecci

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Frontiers in Immunology|December 6, 2021
Pushing Past the Blockade: Advancements in T Cell-Based Cancer ImmunotherapiesJessica Waibl Polania, Emily C Lerner, Daniel S Wilkinson, et al.
Neuro-Oncology Advances|December 3, 2021
Laser interstitial thermal therapy for brain metastasesEthan S Srinivasan, Matthew M Grabowski, Brian V Nahed, et al.
Expert Opinion on Biological Therapy|February 7, 2020
CAR T cells and checkpoint inhibition for the treatment of glioblastomaSteven H Shen, Karolina Woroniecka, Andrew B Barbour, et al.
Journal for Immunotherapy of Cancer|November 1, 2025
Chimeric antigen receptor (CAR) T-cell therapy for glioblastoma (GBM): current clinical insights, challenges, and future directionsChase M Walton, Marcus Bell, Richard O'Neil, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 24, 2014
Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhageVijay Yanamadala, Brian P Walcott, Peter E Fecci, et al.
Expert Opinion on Biological Therapy|March 10, 2017
Prospect of rindopepimut in the treatment of glioblastomaAladine A Elsamadicy, Pakawat Chongsathidkiet, Rupen Desai, et al.
NPJ Precision Oncology|June 7, 2025
Autonomic modulation of the immune response and implications for CNS malignanciesLucas P Wachsmuth, Ethan S Srinivasan, Bhairavy J Puviindran, et al.
Journal of Neuro-Oncology|June 17, 2020
Immune suppression in gliomasMatthew M Grabowski, Eric W Sankey, Katherine J Ryan, et al.
Expert Opinion on Drug Safety|December 20, 2016
The Safety of available immunotherapy for the treatment of glioblastomaS Harrison Farber, Aladine A Elsamadicy, Ahmet Fatih Atik, et al.
Surgical Neurology International|February 28, 2015
Immunotherapy for malignant gliomaCarter M Suryadevara, Terence Verla, Luis Sanchez-Perez, et al.
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|December 6, 2021
Pushing Past the Blockade: Advancements in T Cell-Based Cancer ImmunotherapiesJessica Waibl Polania, Emily C Lerner, Daniel S Wilkinson, et al.
Neuro-Oncology Advances|December 3, 2021
Laser interstitial thermal therapy for brain metastasesEthan S Srinivasan, Matthew M Grabowski, Brian V Nahed, et al.
Expert Opinion on Biological Therapy|February 7, 2020
CAR T cells and checkpoint inhibition for the treatment of glioblastomaSteven H Shen, Karolina Woroniecka, Andrew B Barbour, et al.
Journal for Immunotherapy of Cancer|November 1, 2025
Chimeric antigen receptor (CAR) T-cell therapy for glioblastoma (GBM): current clinical insights, challenges, and future directionsChase M Walton, Marcus Bell, Richard O'Neil, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 24, 2014
Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhageVijay Yanamadala, Brian P Walcott, Peter E Fecci, et al.
Expert Opinion on Biological Therapy|March 10, 2017
Prospect of rindopepimut in the treatment of glioblastomaAladine A Elsamadicy, Pakawat Chongsathidkiet, Rupen Desai, et al.
NPJ Precision Oncology|June 7, 2025
Autonomic modulation of the immune response and implications for CNS malignanciesLucas P Wachsmuth, Ethan S Srinivasan, Bhairavy J Puviindran, et al.
Journal of Neuro-Oncology|June 17, 2020
Immune suppression in gliomasMatthew M Grabowski, Eric W Sankey, Katherine J Ryan, et al.
Expert Opinion on Drug Safety|December 20, 2016
The Safety of available immunotherapy for the treatment of glioblastomaS Harrison Farber, Aladine A Elsamadicy, Ahmet Fatih Atik, et al.
Surgical Neurology International|February 28, 2015
Immunotherapy for malignant gliomaCarter M Suryadevara, Terence Verla, Luis Sanchez-Perez, et al.
Pageof 12